Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations

Parkinsonism and Related Disorders

Volumn 19, Issue 10, 2013, Pages 869-877

  Sundal, Christina ^a,b   Fujioka, Shinsuke ^a   Van Gerpen, Jay A ^a   Wider, Christian ^a   Nicholson, Alexandra M ^a   Baker, Matt ^a   Shuster, Elizabeth A ^a   Aasly, Jan ^c   Spina, Salvatore ^d   Ghetti, Bernardino ^d   Roeber, Sigrun ^e   Garbern, James ^f   Tselis, Alex ^g   Swerdlow, Russell H ^h   Miller, Bradley B ⁱ   Borjesson Hanson, Anne ^b   Uitti, Ryan J ^a   Ross, Owen A ^a   Stoessl, A Jon ^j   Rademakers, Rosa ^a   Josephs, Keith A ^k   Dickson, Dennis W ^a   Broderick, Daniel ^a   Wszolek, Zbigniew K ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

ⁱ TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k MAYO CLINIC ROCHESTER   (United States)

more..

Author keywords

Autosomal dominant; CSF1R mutation; HDLS; Parkinsonism; White matter disorders

Indexed keywords

CARBIDOPA PLUS LEVODOPA; MYELIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; ASTROCYTOSIS; AUTOSOMAL DOMINANT DISORDER; BALANCE IMPAIRMENT; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY STIMULATING FACTOR 1 RECEPTOR GENE; DEGENERATIVE DISEASE; DEMYELINATION; DEPRESSION; DISEASE COURSE; DISEASE DURATION; FAMILY STUDY; FEMALE; GAIT DISORDER; GENE MUTATION; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH SPHEROID; HUMAN; HUMAN TISSUE; MALE; MUSCLE RIGIDITY; NEUROIMAGING; PARKINSONISM; PRIORITY JOURNAL; RECEPTOR GENE; TREMOR; WHITE MATTER LESION;

AUTOSOMAL DOMINANT; CSF1R MUTATION; HDLS; PARKINSONISM; WHITE MATTER DISORDERS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIPARKINSON AGENTS; BIOLOGICAL SPECIMEN BANKS; BRAIN; FAMILY; FEMALE; GAIT DISORDERS, NEUROLOGIC; GLIOSIS; GREAT BRITAIN; HUMANS; HYPOKINESIA; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE RIGIDITY; MUTATION; NEUROIMAGING; PARKINSON DISEASE; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TREMOR; YOUNG ADULT;

EID: 84883277154     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.05.013     Document Type: Article

References (41)

1. Crithely M. Arteriosclerotic parkinsonism. Brain 1929, 52:23-83.
2. Demirkiran M., Bozdemir H., Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001, 104:63-67.
3. Wegner F., Strecker K., Schwarz J., Wagner A., Heinritz W., Sommerer F., et al. Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. JNeurol 2007, 254:1743-1745.
4. Sibon I., Guyot M., Allard M., Tison F. Parkinsonism following anterior choroidal artery stroke. Eur J Neurol 2004, 11:283-284.
5. Netravathi M., Pal P.K., Indira Devi B. Aclinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology. Eur J Neurol 2012, 19:226-233.
6. Brown W.D. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 2000, 13:691-697.
7. Pareyson D., Fancellu R., Mariotti C., Romano S., Salmaggi A., Carella F., et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008, 131:2321-2331.
8. Shachar T., Lo Bianco C., Recchia A., Wiessner C., Raas-Rothschild A., Futerman A.H. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Mov Disord 2011, 26:1593-1604.
9. Finsterer J. Parkinson's syndrome and Parkinson's disease in mitochondrial disorders. Mov Disord 2011, 26:784-791.
10. Saidha S., Mok T.H., Butler M., Fanning N., Harrington H. Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous methylprednisolone. JClin Neurosci 2010, 17:654-655.
11. Raske C., Hagerman P.J. Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome. JInvestig Med 2009, 57:825-829.
12. Perlman S.L. Spinocerebellar degenerations. Handb Clin Neurol 2011, 100:113-140.
13. Loesch D.Z., Kotschet K., Trost N., Greco C.M., Kinsella G., Slater H.R., et al. White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:502-506.
14. Axelsson R., Roytta M., Sourander P., Akesson H.O., Andersen O. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand 1984, 314:1-65.
15. Wider C., Van Gerpen J.A., DeArmond S., Shuster E.A., Dickson D.W., Wszolek Z.K. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?. Neurology 2009, 72:1953-1959.
16. Sundal C., Lash J., Aasly J., Øygarden S., Roeber S., Kretzschman H., et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012 Mar 15, 314(1-2):130-137.
17. Rademakers R., Baker M., Nicholson A.N., Rutherford N.J., Finch N., Soto A., et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012, 44(2):200-205. http://www.nature.com/ng/journal/v44/n2/abs/ng.1027.html#supplementary-information.
18. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatr 1992, 55:181-184.
19. Hughes A.J., Daniel S.E., Blankson S., Lees A.J. Aclinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993, 50:140-148.
20. Fahn S., Jankovic J., Hallett M. Principles and practice of movement disorders 2011, Elsevier Saunders. 2nd ed.
21. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
22. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
23. Baba Y., Ghetti B., Baker M.C., Uitti R.J., Hutton M.L., Yamaguchi K., et al. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol (Berl) 2006, 111:300-311.
24. Van Gerpen J.A., Wider C., Broderick D.F., Dickson D.W., Brown L.A., Wszolek Z.K. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 2008, 71:925-929.
25. Swerdlow R.H., Miller B.B., Lopes M.B., Mandell J.W., Wooten G.F., Damgaard P., et al. Autosomal dominant subcortical gliosis presenting as frontotemporal dementia. Neurology 2009, 72:260-267.
26. Mateen F.J., Keegan B.M., Krecke K., Parisi J.E., Trenerry M.R., Pittock S.J. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. JNeurol Neurosurg Psychiatr 2010, 81:619-622.
27. Ali Z.S., Van Der Voorn J.P., Powers J.M. Acomparative morphologic analysis of adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia - a role for oxidative damage. JNeuropathol Exp Neurol 2007, 66:660-672.
28. Goodman L.E., D D.W. Nonhereditary diffuse leukoencephalopathy with spheroids presenting as early-onset rapidly progressive dementia. JNeuropathol Exp Neurol 1995, 54:471.
29. Mayer B., Oelschlaeger C., Keyvani K., Niederstadt T. Two cases of LENAS: diagnosis by MRI and biopsy. JNeurol 2007, 254:1453-1454.
30. Ropper A.H., Adams R.D., Victor M., Samuels M.A. Adams and Victor's principles of neurology 2009, McGraw-Hill Medical, New York. 9th ed.
31. Sundal C., Wider C., Van Gerpen J.A., Lash J., Garbern J.Y., Schweitzer K.J., et al. MRI in HDLS shows a unique mechanism of neuroaxonal degeneration 2011, 33. American Neurological Association 2011 Book of Abstracts, 09/2011(S204).
32. Bonilha L., de Vries P.M., Hurd M.W., Rorden C., Morgan P.S., Besenski N., et al. Disrupted thalamic prefrontal pathways in patients with idiopathic dystonia. Parkinsonism Relat Disord 2009, 15:64-67.
33. Whitwell J.L., Avula R., Master A., Vemuri P., Senjem M.L., Jones D.T., et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 2011, 17:599-605.
34. de Laat K.F., Tuladhar A.M., van Norden A.G., Norris D.G., Zwiers M.P., de Leeuw F.E. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 2011, 134:73-83.
35. Bohnen N.I., Muller M.L., Zarzhevsky N., Koeppe R.A., Bogan C.W., Kilbourn M.R., et al. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain 2011, 134:2358-2365.
36. Wenning G.K., Litvan I., Tolosa E. Milestones in atypical and secondary parkinsonisms. Mov Disord 2011, 26:1083-1095.
37. Bohnen N.I., Albin R.L. White matter lesions in Parkinson disease. Nat Rev Neurol 2011, 7:229-236.
38. Nutt J.G., Bloem B.R., Giladi N., Hallett M., Horak F.B., Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 2011, 10:734-744.
39. Snijders A.H., Leunissen I., Bakker M., Overeem S., Helmich R.C., Bloem B.R., et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 2011, 134:59-72.
40. Nachev P., Kennard C., Husain M. Functional role of the supplementary and pre-supplementary motor areas. Nat Rev Neurosci 2008, 9:856-869.
41. Preziosa P., Rocca M.A., Mesaros S., Pagani E., Stosic-Opincal T., Kacar K., et al. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. Radiology 2011, 260:541-550.